Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
8.05
+0.22 (2.81%)
Nov 28, 2025, 1:00 PM EST - Market closed

Journey Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
218821073490-
Upgrade
Market Cap Growth
88.87%-23.38%212.54%-61.94%--
Upgrade
Enterprise Value
219808525109-
Upgrade
Last Close Price
8.073.915.761.925.38-
Upgrade
PS Ratio
3.131.461.350.461.42-
Upgrade
PB Ratio
8.224.075.242.012.13-
Upgrade
P/TBV Ratio
--1692.20-3.04-
Upgrade
P/FCF Ratio
--20.35---
Upgrade
P/OCF Ratio
--20.35---
Upgrade
EV/Sales Ratio
3.691.431.070.331.73-
Upgrade
EV/EBITDA Ratio
--17.57---
Upgrade
EV/EBIT Ratio
--79.43---
Upgrade
EV/FCF Ratio
--16.22---
Upgrade
Debt / Equity Ratio
0.981.280.871.570.221.76
Upgrade
Debt / EBITDA Ratio
--3.59--1.93
Upgrade
Debt / FCF Ratio
--3.38--3.52
Upgrade
Asset Turnover
0.800.720.870.730.851.04
Upgrade
Inventory Turnover
1.711.701.882.564.5412.91
Upgrade
Quick Ratio
1.080.871.020.901.401.15
Upgrade
Current Ratio
1.421.371.351.161.641.26
Upgrade
Return on Equity (ROE)
-47.05%-72.60%-20.64%-100.39%-168.12%81.00%
Upgrade
Return on Assets (ROA)
-4.60%-10.88%0.73%-16.99%-15.79%11.44%
Upgrade
Return on Capital (ROIC)
-8.26%-20.39%1.64%-36.32%-29.64%23.71%
Upgrade
Return on Capital Employed (ROCE)
-12.10%-30.30%3.10%-71.80%-41.30%32.90%
Upgrade
Earnings Yield
-3.96%-17.96%-3.61%-86.86%-49.09%-
Upgrade
FCF Yield
-1.80%-11.17%4.92%-39.68%-2.43%-
Upgrade
Buyback Yield / Dilution
-16.55%-12.06%-4.00%-72.05%5.96%-7.55%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q